Market Overview:
The global insomnia market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing prevalence of insomnia, growing awareness about available treatment options, and rising demand for better-quality sleep. The pharmacological therapy segment is expected to dominate the global insomnia market in terms of revenue share during the forecast period. This can be attributed to the high adoption rate of pharmacological therapies for treating insomnia and their efficacy in providing relief from symptoms associated with this disorder. However, non-pharmacological therapies are gaining traction due to their safety and lack of side effects compared with pharmacological therapies. In terms of application, the female segment is expected to account for a larger share of the global insomnia market than male and senior citizens segments during the forecast period.
Product Definition:
Insomnia is a sleep disorder that can cause problems such as fatigue, daytime sleepiness, difficulty concentrating, and irritability.
Pharmacological Therapy:
Pharmacological therapy is the use of drugs to treat a medical condition. The most common type of pharmacological therapy used for insomnia is prescription sleeping pills or generic forms of them such as melatonin. However, there are other options available like non-pharmacological therapies which include behavioral therapies and devices that help in creating an environment conducive to sleep such as darkroom timers and alarm clocks with personalized settings.
Non-pharmacological Therapy:
Non-pharmacological therapy and it's usage in insomnia market: The non-pharmacological treatment of sleep disorders includes behavioral therapy, light exposure, melatonin supplements, and other natural remedies. According to the National Sleep Foundation’s (NSF) survey results; one out of three people in U.S experience insomnia each year which costs an average individual around USD 450 per month for treatment.
Application Insights:
On the basis of application, the global insomnia market is segmented into female, male and senior citizens. The female segment held a major share in 2017 owing to rising awareness about sleep disorders among women and increasing prevalence of sleeping disorders. According to WHO, around 50% of women get less than six hours of sleep every night while 35%of men get enough sleep every night. Furthermore, increase in working population as well as student population increases the risk for developing insomnia disorder due to lack of proper rest.
The male segment is expected to grow at a significant rate during the forecast period owing to increase in stress levels among males above 18 years old worldwide including India on account of competitive exams followed by work pressure which leads them towards unhealthy habits like drinking alcohol or using drugs which further damages their health causing insomnia disorder along with other health issues such as heart diseases or high blood pressure etc.
Regional Analysis:
North America dominated the global insomnia market in 2017. The region is expected to continue its dominance over the forecast period as well due to increasing cases of sleep disorders, rising awareness about these disorders, and growing availability of effective treatment options. For instance, according to a study published in Sleep Medicine Clinics by Harvard Medical School’s Department of Medicine, more than 30 million adults in U.S. suffer from insomnia disorder each year and around 6% of them are suffering from severe form which requires pharmacological or surgical intervention for proper treatment.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing awareness about various treatments available for different sleep disorders coupled with rising healthcare expenditure by governments across countries such as China & India & Japan etc.
Growth Factors:
- Increasing awareness about the benefits of good sleep hygiene
- Rising prevalence of stress and anxiety disorders
- Growing demand for better quality sleep products and services
- Proliferation of digital media and technology-related distractions in bedtime routines
- Increased research on sleep and its effects on overall health
Scope Of The Report
Report Attributes
Report Details
Report Title
Insomnia Market Research Report
By Type
Pharmacological Therapy, Non-pharmacological Therapy
By Application
Female, Male, Senior Citizens
By Companies
Merck, Eisai, Meda Consumer Healthcare, Takeda Pharmaceuticals, Pfizer, Sanofi, Vanda Pharmaceuticals, Pernix Therapeutics, Purdue Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
174
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Insomnia Market Report Segments:
The global Insomnia market is segmented on the basis of:
Types
Pharmacological Therapy, Non-pharmacological Therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Female, Male, Senior Citizens
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Eisai
- Meda Consumer Healthcare
- Takeda Pharmaceuticals
- Pfizer
- Sanofi
- Vanda Pharmaceuticals
- Pernix Therapeutics
- Purdue Pharmaceuticals
Highlights of The Insomnia Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pharmacological Therapy
- Non-pharmacological Therapy
- By Application:
- Female
- Male
- Senior Citizens
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Insomnia Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Insomnia is a sleep disorder in which people have difficulty falling asleep or staying asleep. People with insomnia may experience problems falling asleep, staying asleep, or both. Insomnia can be mild or severe, and can last for weeks, months, or years.
Some of the major companies in the insomnia market are Merck, Eisai, Meda Consumer Healthcare, Takeda Pharmaceuticals, Pfizer, Sanofi, Vanda Pharmaceuticals, Pernix Therapeutics, Purdue Pharmaceuticals.
The insomnia market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Insomnia Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Insomnia Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Insomnia Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Insomnia Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Insomnia Market Size & Forecast, 2018-2028
4.5.1 Insomnia Market Size and Y-o-Y Growth
4.5.2 Insomnia Market Absolute $ Opportunity
Chapter 5 Global Insomnia Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Insomnia Market Size Forecast by Type
5.2.1 Pharmacological Therapy
5.2.2 Non-pharmacological Therapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Insomnia Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Insomnia Market Size Forecast by Applications
6.2.1 Female
6.2.2 Male
6.2.3 Senior Citizens
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Insomnia Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Insomnia Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Insomnia Analysis and Forecast
9.1 Introduction
9.2 North America Insomnia Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Insomnia Market Size Forecast by Type
9.6.1 Pharmacological Therapy
9.6.2 Non-pharmacological Therapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Insomnia Market Size Forecast by Applications
9.10.1 Female
9.10.2 Male
9.10.3 Senior Citizens
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Insomnia Analysis and Forecast
10.1 Introduction
10.2 Europe Insomnia Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Insomnia Market Size Forecast by Type
10.6.1 Pharmacological Therapy
10.6.2 Non-pharmacological Therapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Insomnia Market Size Forecast by Applications
10.10.1 Female
10.10.2 Male
10.10.3 Senior Citizens
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Insomnia Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Insomnia Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Insomnia Market Size Forecast by Type
11.6.1 Pharmacological Therapy
11.6.2 Non-pharmacological Therapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Insomnia Market Size Forecast by Applications
11.10.1 Female
11.10.2 Male
11.10.3 Senior Citizens
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Insomnia Analysis and Forecast
12.1 Introduction
12.2 Latin America Insomnia Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Insomnia Market Size Forecast by Type
12.6.1 Pharmacological Therapy
12.6.2 Non-pharmacological Therapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Insomnia Market Size Forecast by Applications
12.10.1 Female
12.10.2 Male
12.10.3 Senior Citizens
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Insomnia Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Insomnia Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Insomnia Market Size Forecast by Type
13.6.1 Pharmacological Therapy
13.6.2 Non-pharmacological Therapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Insomnia Market Size Forecast by Applications
13.10.1 Female
13.10.2 Male
13.10.3 Senior Citizens
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Insomnia Market: Competitive Dashboard
14.2 Global Insomnia Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Eisai
14.3.3 Meda Consumer Healthcare
14.3.4 Takeda Pharmaceuticals
14.3.5 Pfizer
14.3.6 Sanofi
14.3.7 Vanda Pharmaceuticals
14.3.8 Pernix Therapeutics
14.3.9 Purdue Pharmaceuticals
